Your browser doesn't support javascript.
loading
Targeted MS Assay Predicting Tamoxifen Resistance in Estrogen-Receptor-Positive Breast Cancer Tissues and Sera.
De Marchi, Tommaso; Kuhn, Erik; Dekker, Lennard J; Stingl, Christoph; Braakman, Rene B H; Opdam, Mark; Linn, Sabine C; Sweep, Fred C G J; Span, Paul N; Luider, Theo M; Foekens, John A; Martens, John W M; Carr, Steven A; Umar, Arzu.
Afiliación
  • De Marchi T; Erasmus University Medical Center Rotterdam , Erasmus MC Cancer Institute, Department of Medical Oncology, 3015 CN Rotterdam, The Netherlands.
  • Kuhn E; Postgraduate School of Molecular Medicine, Erasmus University Medical Center , 3015 CN Rotterdam, The Netherlands.
  • Dekker LJ; Broad Institute of MIT and Harvard , Cambridge, Massachusetts 02142, United States.
  • Stingl C; Erasmus University Medical Center Rotterdam , Department of Neurology, 3015 CN Rotterdam, The Netherlands.
  • Braakman RB; Erasmus University Medical Center Rotterdam , Department of Neurology, 3015 CN Rotterdam, The Netherlands.
  • Opdam M; Erasmus University Medical Center Rotterdam , Erasmus MC Cancer Institute, Department of Medical Oncology, 3015 CN Rotterdam, The Netherlands.
  • Linn SC; Postgraduate School of Molecular Medicine, Erasmus University Medical Center , 3015 CN Rotterdam, The Netherlands.
  • Sweep FC; Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Division of Medical Oncology, 1066 CX Amsterdam, The Netherlands.
  • Span PN; Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Division of Medical Oncology, 1066 CX Amsterdam, The Netherlands.
  • Luider TM; Radboud University Medical Center , Department of Laboratory Medicine, 6525 GA Nijmegen, The Netherlands.
  • Foekens JA; Radboud University Medical Center , Department of Radiation Oncology, 6525 GA Nijmegen, The Netherlands.
  • Martens JW; Erasmus University Medical Center Rotterdam , Department of Neurology, 3015 CN Rotterdam, The Netherlands.
  • Carr SA; Erasmus University Medical Center Rotterdam , Erasmus MC Cancer Institute, Department of Medical Oncology, 3015 CN Rotterdam, The Netherlands.
  • Umar A; Broad Institute of MIT and Harvard , Cambridge, Massachusetts 02142, United States.
J Proteome Res ; 15(4): 1230-42, 2016 Apr 01.
Article en En | MEDLINE | ID: mdl-26958999

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tamoxifeno / Neoplasias de la Mama / Biomarcadores de Tumor / Resistencia a Antineoplásicos / Antineoplásicos Hormonales / Ensayos Analíticos de Alto Rendimiento Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: J Proteome Res Asunto de la revista: BIOQUIMICA Año: 2016 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tamoxifeno / Neoplasias de la Mama / Biomarcadores de Tumor / Resistencia a Antineoplásicos / Antineoplásicos Hormonales / Ensayos Analíticos de Alto Rendimiento Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: J Proteome Res Asunto de la revista: BIOQUIMICA Año: 2016 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos